MetLife Investment Management, LLC

MetLife Investment Management bought 1.00M shares at $25.00 on 2025-05-29 ($25,000,000.00)

MetLife Investment Management, a 10% owner of DPG, executed 2 separate purchases totaling 1,000,000 shares for $25,000,000.00 at $25.00 per share on 2025-05-29. The current market price of $12.29 is substantially below the transaction price, representing a significant decline since acquisition. This purchase occurs in a context of the insider's poor cross-ticker track record: across all open-market history, the insider has 10 prior buys with an average 90-day return of -53.1% and a 90-day win rate of 0.00%. The combination of a large-scale purchase at a price now 51% above current market levels, paired with a consistent pattern of negative post-purchase returns across the insider's broader portfolio activity, creates a notable risk signal for investors evaluating DPG's near-term outlook.

MetLife Investment Management bought 1.00M shares of FAX for $1,000,000,000,000.00 on 2025-01-09; stock down 14.2% from 52-week high.

MetLife Investment Management, a 10% owner, executed a $1,000,000,000,000.00 purchase of 1.00M shares of ABRDN ASIA-PACIFIC INCOME FUND, INC. on 2025-01-09, at a time when the stock trades 14.2% below its 52-week high of $17.51 and has declined 11.2% over 90 days. Reviewing the insider's cross-ticker track record reveals a stark pattern: across 9 prior open-market buys, the average 90-day return was -47.9% with a 0.00% win rate, indicating a consistent tendency for the stock to decline further after purchase. The combination of this massive single acquisition and the historical pattern of poor post-purchase performance across the insider's portfolio warrants heightened scrutiny of the investment thesis and forward catalysts.

MetLife Investment Management (10% owner) bought 840,000 shares at $25.00 for $21,000,000.00 on 2024-09-09

MetLife Investment Management, a 10% shareholder, executed 3 separate purchases totaling 840,000 shares for $21,000,000.00 at $25.00 per share on 2024-09-09. The current market price of $11.46 stands 4.7% below the 52-week high and 54% below the transaction price, indicating a substantial decline in valuation post-purchase. The insider's cross-ticker track record shows 6 prior buys with an average 30-day return of -100.0%, suggesting a pattern of unfavorable transaction timing across holdings. The post-transaction holding of 92,000 shares against a pre-transaction position of -748,000 shares reflects a significant portfolio adjustment, though the negative pre-position warrants clarification on the nature of prior obligations or short positions.

MetLife Investment Management acquired 800,000 shares ($20,000,000) in CHY at $25.00 on 2024-09-09, now trading at $11.64.

MetLife Investment Management, a 10% owner, executed 3 separate purchases totaling 800,000 shares for $20,000,000.00 at a blended average price of $25.00 on 2024-09-09. The stock currently trades at $11.64, representing a significant decline from the transaction price. The insider's cross-ticker track record shows 6 prior buys with an average 30-day return of -100.0%, indicating a consistent pattern of unfavorable outcomes on prior purchases across other securities. The large capital deployment into this position warrants monitoring of whether the investment thesis has shifted.

MetLife Investment Management (10% owner) buys 440,000 shares of CCD for $11,000,000 on 2024-09-09 at $25.00

MetLife Investment Management, a 10% shareholder, executed 2 separate purchases totaling 440,000 shares for $11,000,000.00 at $25.00 per share on 2024-09-09. The current price of $23.99 sits at the 52-week high, indicating the purchase was made at a premium to recent market levels. Notably, this insider's cross-ticker track record shows 7 prior buys with an average 30-day return of -100.0%, suggesting a consistent pattern of unfavorable timing on open-market purchases across holdings. The filing does not disclose a 10b5-1 plan or other rule mechanism, indicating these were discretionary trades, yet the poor historical outcomes raise questions about execution quality or market selection on this series of purchases.

MetLife Investment Management (10% owner) purchases 3,100,000 shares of DNP at $3,100,000.00 on 2024-07-22; position value $9,610,000,000,000.00.

MetLife Investment Management, already a 10% owner, executed a substantial acquisition of 3,100,000 shares valued at $9,610,000,000,000.00 on 2024-07-22. The current price of $8.71 is -15.3% from the 52-week high of $10.28, placing the purchase in a drawdown period; however, the stock has recovered +5.6% over the prior 30 days. This scale of accumulation by a major institutional stakeholder warrants examination of whether it reflects portfolio rebalancing by an asset manager or a signal regarding the fund's positioning. The transaction's magnitude and the purchaser's already-significant ownership stake make this material for investors monitoring DNP's shareholder composition and institutional conviction.